The Evidence

When the illness came before the explanation: why “illness before awareness” could change the MCS debate

Illness before awareness is one of the most important unanswered causal questions in MCS. If people became sick before they knew an exposure had occurred or before they suspected chemicals, that chronology directly tests explanations based on expectation or fear at onset. Existing literature suggests this pattern occurs, but it has not been measured rigorously enough; the registry should.

One of the most important questions in MCS has barely been measured: were people already sick before they knew, suspected, or believed that an environmental exposure was involved?

The question hiding in plain sight

For decades, arguments about Multiple Chemical Sensitivity have focused on what happens after a person already knows that fragrance, solvent, smoke, pesticide, or another environmental exposure can make them ill. That is where expectation, conditioning, fear, and nocebo effects are usually studied.

But there is a more fundamental question: what happened at the beginning?

If a person developed unexplained multisystem illness first, sought medical help, changed jobs, missed work, or accumulated contemporaneous medical records — and only later discovered that a pesticide application, remodeling event, workplace solvent, mold problem, or other exposure had been present — that chronology is scientifically important. It does not prove the mechanism. But it directly tests the claim that the illness began because the person expected an exposure to make them sick.

What we know

Existing onset studies show that identifiable environmental events are common in MCS and chemical-intolerance histories, but they do not answer the chronology question cleanly enough.

In 1995, Miller and Mitzel studied 112 people who reported onset of chemical sensitivity after either a well-documented cholinesterase-inhibiting pesticide exposure or building remodeling. The two groups later reported similar patterns of symptoms and triggers despite different initiating environments. That study was important because the exposures were concrete enough to compare, but participants were recruited after they had already made the exposure connection.

In a 1999 comparison using the EESI, Miller and Prihoda included 96 MCS patients who attributed illness onset to a specific exposure event and 90 MCS patients who did not. The fact that a large MCS group did not attribute onset to one event is itself a warning against assuming that every patient has a dramatic, recognized “poisoning story.” But again, the study did not reconstruct exactly when illness began relative to awareness of the exposure.

A 2023 U.S. population survey of 10,981 adults found that about half of chemically intolerant respondents who were asked about initiation did not identify an initiating exposure. Among those who did, mold, pesticides, medical or surgical events, remodeling or new construction, combustion products, and implants were reported. The study is useful for mapping candidate initiators, but it relied on retrospective attribution and was not designed to determine whether illness preceded awareness.

Why this matters to the psychological argument

Provocation studies can show that expectation shapes some reactions after MCS exists; they cannot explain an illness that began before the patient knew what exposure to fear. That chronology is why Illness Before Awareness matters. A later expectation effect cannot travel backward in time and create an earlier unexplained illness.

That is why “Illness Before Awareness” is different from asking whether someone can react more strongly when they know a chemical is present. The proposed study asks whether the causal story itself was already in the patient’s mind when the illness began.

If a large, carefully characterized group meeting established MCS criteria has contemporaneous evidence of illness that predates environmental attribution, a simple “belief created the disorder” explanation becomes much harder to sustain for that group. If, on the other hand, illness usually begins only after an exposure has been identified and feared, that would also be important evidence. The study must be able to find either result.

How to study it without leading people

The registry should not ask, “Which chemical poisoned you?” That would assume the answer. It should reconstruct sequence.

Key questions include: When did the first persistent symptoms begin? What were they? At that time, did you suspect an environmental cause? Did you know that a potentially relevant exposure had occurred? If not, when did you first suspect one? What led you to that suspicion? Are there medical, employment, building, pesticide, military, or other records dated before the environmental explanation emerged?

We also need to distinguish several groups: exposure known before symptoms; exposure and illness recognized at roughly the same time; illness first and exposure discovered later; and no initiating exposure ever identified. Those are different histories and should not be blended.

The most valuable records may already exist

One reason this study could be unusually persuasive is that it can sometimes move beyond memory. Medical records may document headaches, respiratory symptoms, cognitive changes, gastrointestinal illness, fatigue, abnormal autonomic symptoms, or repeated unexplained visits before the patient had an environmental explanation. Workplace records may show a remodeling project or pesticide treatment. Building records may document water damage. Coworkers may independently recall a shared exposure.

Pre-attribution records are not perfect proof. A symptom recorded before awareness can still have many causes. But they sharply reduce one of the largest problems in retrospective MCS research: the possibility that later beliefs rewrote the story of onset.

What the registry is answering

Illness Before Awareness should be one of the Canary Registry’s flagship studies. It is inexpensive compared with laboratory research, scalable internationally, and directly addresses a causal question that has been argued about for decades without enough chronology.

The registry should collect chronology first and interpretation second. It should also invite participants, where they choose, to authorize review of pre-attribution records so that a future peer-reviewed study can compare remembered chronology with contemporaneous documentation.

The goal is not to produce a predetermined percentage. The goal is to learn which sequence actually occurs, how often, and whether different onset sequences predict different later phenotypes.

Where we stand

The evidence already supports MCS as a physiological, environmentally initiated and environmentally triggered disorder in people meeting established criteria. But the exact path from exposure to established illness remains under investigation.

Illness Before Awareness is one of the cleanest ways to test a central competing explanation. Instead of arguing about whether patients “believe” chemicals make them sick today, we ask the more important question: were they already sick before they knew what to believe?

We followed the evidence. Here’s where it leads →

Sources

Study populations and limitations are described above; inclusion does not mean every study used the 1999 consensus case definition.

1Miller CS, Mitzel HC. Chemical sensitivity attributed to pesticide exposure versus remodeling. Arch Environ Health 1995;50(2):119-29. PMID: 7786048. DOI: 10.1080/00039896.1995.9940889

2Miller CS, Prihoda TJ. A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients and persons with multiple chemical sensitivity. Toxicol Ind Health 1999;15(3-4):386-97. PMID: 10416290. DOI: 10.1177/074823379901500312

3Miller CS, Prihoda TJ. The Environmental Exposure and Sensitivity Inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications. Toxicol Ind Health 1999;15(3-4):370-85. PMID: 10416289. DOI: 10.1177/074823379901500311

4Miller CS et al. What initiates chemical intolerance? Findings from a large population-based survey of U.S. adults. Environmental Sciences Europe. 2023. DOI: 10.1186/s12302-023-00772-x

← Back to MCSDisability.com

↑